https://www.selleckchem.com/pr....oducts/bozitinib.htm
The total number of these operations in April and May 2019 dropped by 79% for the same period in 2020. An estimate of 79% of patients, who had been presenting for laryngeal and/or oropharyngeal neoplasms, did not show up due to indirect COVID-19 effect. An estimate of 79% of patients, who had been presenting for laryngeal and/or oropharyngeal neoplasms, did not show up due to indirect COVID-19 effect. A retrospective study was undertaken of a cohort of facially injured patients using matched 8-week periods non-COVID (2019) and COVID (